From MEDPAGE TODAY
U.S. Psychiatric & Mental Health Congress
San Francisco, CA • April 21, 2007
New Definitions on Tap for Mixed Manias SAN FRANCISCO -- Dysphoric mania and other mixed mania states of bipolar disorder will become easier to diagnose with better definitions, a researcher said here. http://www.medpagetoday.com/MeetingCoverage/USPsychiatricMentalHealthCongress/mr/5511
Insomnia Treatment Boosts Antidepressant Efficacy SAN FRANCISCO -- A significant number of patients with major depression also suffer from chronic insomnia that hampers recovery, and treating the insomnia may improve both conditions. http://www.medpagetoday.com/MeetingCoverage/USPsychiatricMentalHealthCongress/mr/5510
Atypical Antipsychotic Medication Cuts Behavioral Symptoms in Autism SAN FRANCISCO -- While the behavioral symptoms of autism have been treated with a wide spectrum of medications, atypical antipsychotics may be the most effective drug class.
http://www.medpagetoday.com/MeetingCoverage/USPsychiatricMentalHealthCongress/mr/5509
Depression Remission Rates Remain Low, But There’s Hope SAN FRANCISCO -- Remission rates remain low for major depression even with multiple antidepressant drug classes available, but the recently approved selegiline patch (Emsam) aims to bring the rates up. http://www.medpagetoday.com/MeetingCoverage/USPsychiatricMentalHealthCongress/mr/5508
Vigilance Still Necessary for Atypical Antipsychotics SAN FRANCISCO -- Atypical antipsychotic medications have improved adverse-event profiles compared with the older generation of antipsychotics, but careful attention to major side effects is still required. http://www.medpagetoday.com/MeetingCoverage/USPsychiatricMentalHealthCongress/mr/5507
Concurrent Treatment Works for ComorbidADHD and Substance Abuse SAN FRANCISCO -- Given the high prevalence of substance abuse in patients with attention deficit hyperactivity disorder (ADHD), psychiatrists need to consider comorbidity in assessment of both conditions. http://www.medpagetoday.com/MeetingCoverage/USPsychiatricMentalHealthCongress/mr/5501